×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Asian Town Hall
Session Chair(s)
Nobumasa Nakashima
Health Policy Director, National Healthcare Policy Secretariat
Cabinet Office, Japan
“Regulatory convergence” has been advancing in Asia and expectation to this region as a field of drug development is also increasing. This session shares latest efforts for “regulatory convergence” in Asia and discuss future direction.
Learning Objective : Describe activities to promote convergence in Asian country; Discuss activities based on convergence in Asian country; Discuss findings from FDA’s perspective.
Speaker(s)
NMPA Perspective
Si Yuan Zhou
National Medical Products Adminsitration (NMPA), China
Director of CDE, Head of ICH China Office
ASEAN Convergence in Pharmaceutical Inspections
Sia Chong Hock, MSc
Health Sciences Authority (HSA), Singapore
Senior Consultant, Audit and Licensing, Director Quality Assurance
FDA Perspective
Michelle Limoli, PharmD, RPh
FDA, United States
Senior International Health Science Advisor, Office of the Director, CBER
Have an account?